JPMorgan cuts Generali to Neutral after strong re-rating
Investing.com -- JPMorgan downgraded Generali to Neutral from Overweight, citing a strong re-rating that has seen the stock outperform the European insurance sector by more than 45% since the start of 2024. Shares now trade at roughly 12 times 2027 earnings, broadly in line with major European composite insurers and the sector average.
Reported by 1 outlet — Investing.com · Stock Market. See all sources ↓
Investing.com -- JPMorgan downgraded Generali to Neutral from Overweight, citing a strong re-rating that has seen the stock outperform the European insurance sector by more than 45% since the start of 2024. Shares now trade at roughly 12 times 2027 earnings, broadly in line with major European composite insurers and the sector average. The Wall Street bank raised its December 2027 price target to €46 from €44. Analysts led by Farooq Hanif noted that their estimated 2027 total capital return yield of about 5% sits below the composite peer average.
Read the full report at Investing.com · Stock Market ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- Investing.com -- JPMorgan downgraded Generali to Neutral from Overweight, citing a strong re-rating that has seen the stock outperform the European insurance sector by more than 45% since the start of 2024. Shares now trade at roughly 12 times 2027 earnings, broadly in line with major European composite insurers and the sector average.
- How widely is it covered?
- 1 outlet, average source rating 6.0/10.
- When was it last updated?
- 1m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
JPMorgan cuts Generali to Neutral after strong re-rating
Sources1TypeCoverageInvesting.com · Stock Market